GlassScriptPhysician profile
Arjun V Gururaj
NPI 1407801624
$399,228.73
in general payments reported to CMS, 2019-2025
38 companies · $88K in 2025
The $88K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54K · 2020: $65K · 2021: $46K · 2022: $67K · 2023: $21K · 2024: $59K · 2025: $88K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $72K · Travel and Lodging: $36K · Food and Beverage: $29K · Consulting Fee: $27K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $72,142.00 |
| Travel and Lodging | $36,078.55 |
| Food and Beverage | $29,458.83 |
| Consulting Fee | $27,125.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acutus Medical, INC. | $122,874.01 | 2019-2023 | |
| Medtronic, INC. | $105,805.54 | 2023-2025 | Affera Mapping System, Pulseselect, Micra |
| Abbott Laboratories | $86,190.86 | 2019-2025 | Amplatzer Amulet, Na, Ensite |
| Biotronik INC. | $31,719.30 | 2019-2025 | Edora 8 Dr-T, Rivacor 7 Dr-T, Selectra |
| Cardiofocus, INC. | $18,905.13 | 2019-2025 | Heartlight System |
| Cvrx, INC. | $16,440.16 | 2019-2025 | Barostim Neo System |
| Impulse Dynamics (USA) INC. | $2,845.85 | 2020-2025 | Optimizer, Optimizer |
| Biosense Webster, INC. | $2,624.38 | 2019-2025 | Carto 3, Decanav, Visitag Surpoint External Processing Unit |
| Cardiva Medical, INC. | $1,599.14 | 2020-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f, Ensoetm |
| Zoll Respicardia, INC. | $1,537.13 | 2019-2025 | Remede System |
| Inspire Medical Systems, INC. | $1,515.26 | 2021-2025 | Inspire |
| Boston Scientific Corporation | $1,430.46 | 2019-2024 | Rhythmia Mapping System, Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Atricure, INC. | $1,220.24 | 2019-2024 | |
| Medtronic Vascular, INC. | $633.79 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $518.87 | 2020-2025 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arjun Gururaj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.